Lantheus Holdings (LNTH) Retained Earnings (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Retained Earnings came in at $797.9 million in Q1 2026, up 45488.0% year-on-year from N/an in Q1 2025, and up 61149.81% on a QoQ basis from -$1.3 million in Q4 2025.

Lantheus Holdings (LNTH) Retained Earnings (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Retained Earnings data on file, last reported at $797.9 million in Q1 2026.

  • On a quarterly basis, Retained Earnings rose 45488.0% year-over-year to $797.9 million in Q1 2026; TTM through Mar 2026 was $797.9 million, a 45488.0% increase from a year earlier, with the FY2025 full-year figure at -$1.3 million, up 19.07% from the prior year.
  • Retained Earnings for Q1 2026 stood at $797.9 million, up from -$1.3 million in the prior quarter.
  • Over the last five years, Retained Earnings for LNTH reached as high as $797.9 million in Q1 2026 and fell as low as -$178.3 million in Q1 2022.
  • Historically, Retained Earnings has averaged $98.0 million across 5 years, with a median of -$1.2 million in 2024.
  • Across the five-year window, Retained Earnings tumbled 159.59% in 2022 and soared 53737.74% in 2025, its largest moves.
  • Year by year, Retained Earnings stood at -$1.3 million in 2022, then soared by 10703.89% to $133.5 million in 2023, then plunged by 101.21% to -$1.6 million in 2024, then gained by 19.07% to -$1.3 million in 2025, then soared by 61149.81% to $797.9 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were $797.9 million in Q1 2026, -$1.3 million in Q4 2025, and $625.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 797.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 797.92 Mn
Dec 31, 2025 -1.31 Mn
Sep 30, 2025 625.42 Mn
Jun 30, 2025 -1.48 Mn
Mar 31, 2025 -1.76 Mn
Dec 31, 2024 -1.62 Mn
Sep 30, 2024 -1.17 Mn
Jun 30, 2024 -1.21 Mn
Mar 31, 2024 264.57 Mn
Dec 31, 2023 133.50 Mn
Sep 30, 2023 30.12 Mn
Jun 30, 2023 -952,000.00
Mar 31, 2023 -1.38 Mn
Dec 31, 2022 -1.26 Mn
Sep 30, 2022 2.99 Mn
Jun 30, 2022 2.32 Mn
Mar 31, 2022 -178.26 Mn
Dec 31, 2021 -485,000.00
Sep 30, 2021 -1.14 Mn
Jun 30, 2021 -1.00 Mn